DSFIR KONINKLIJKE DSM N.V.

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

Press Release

Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025

dsm-firmenich, innovators in nutrition, health, and beauty, is pleased to announce the appointment of Laetitia Pictet as Chief Legal, Risk and Compliance Officer (CLRCO), effective May 1, 2025. She succeeds Jane Sinclair, who is retiring after a distinguished career.

Laetitia Pictet brings over 25 years of senior legal expertise across Europe, the Americas, and Asia. She currently serves as SVP Corporate Secretary and Enterprise Risk Management and has been an invaluable senior member in the company’s legal team since joining in 2015. In her new role as CLRCO, Laetitia will join the company’s Executive Committee, reporting directly to CEO Dimitri de Vreeze.

Jane Sinclair retires as dsm-firmenich’s Chief Legal, Risk, Regulatory and Compliance Officer on April 30, 2025, after nearly a decade in the role and a legal career spanning more than three decades. Her extensive experience includes senior advisory roles in corporate law, general counsel, company secretary, corporate governance, capital markets, M&A, and corporate litigation. Jane will stay on as advisor to the CEO through the end of 2026.

Dimitri de Vreeze, CEO, commented: “I am thrilled to welcome Laetitia to our Executive Committee as Chief Legal, Risk and Compliance Officer. Her exceptional skills and dedication are a tremendous asset to our company. Laetitia's deep legal expertise and unwavering commitment to excellence are consistently driving impactful results, fostering a culture of integrity and compliance. I am also deeply grateful for Jane’s leadership and outstanding legal counsel during a period of significant transformation at dsm-firmenich. Her astute guidance and significant contributions have been invaluable in establishing dsm-firmenich. We will miss her warm personality and great spirit, and we wish her all the best in her well-deserved retirement.”

Laetitia, a Swiss national, began her legal career in the pharmaceutical industry. She joined Firmenich as VP Senior Legal Counsel in 2015 and was swiftly promoted to SVP Head of Commercial Legal in 2018. In 2021, she took on the additional role of Secretary of the Board. Following the completion of the merger in 2023, Laetitia assumed the responsibilities of Corporate Secretary for dsm-firmenich, alongside Risk Management.

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. 

       

For more information

Media relations

Robin Roothans

tel. +41 (0)79 280 03 96

e-mail

Investor relations

Dave Huizing

tel. +31 (0)88 425 7306

e-mail

Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich’s future performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance, transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.

Attachment



EN
08/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on KONINKLIJKE DSM N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aedifica and Cofinimmo: Aedifica acquires c.80% of the shares in Cofinimmo. ASM International: 4Q25 results; strong FY26 guidance. D'Ieteren: Bloomberg reports on Belron IPO, valuation above $30bn, close to $40bn. dsm-firmenich: Symrise 2025 results and guidance. Kinepolis: Feb reassures - US box office revenue up +1% YoY, France visitors up +25% YoY. KPN: Odido data breach

 PRESS RELEASE

dsm-firmenich cancels its shares following completion of its €1.08 bil...

dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces that following the completion of its €1.08 billion share buyback program in 2025, the company has cancelled 12,049,441 shares. As a result, the total number of issued shares has been reduced by approximately 4.5%, from 265,676,388 to 253,62...

 PRESS RELEASE

dsm-firmenich publishes 2025 Integrated Annual Report

dsm-firmenich publishes 2025 Integrated Annual Report Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrated Annual Report (IAR) for 2025, a year during which the company advanced its innovation-led growth agenda, sharpened its strategic profile, and delivered a good performance. The 2025 IAR offers a comprehensive overview of dsm-firmenich’s financial and non-financial progress during the past year. It details the Group’s performance, inclu...

Guy Sips ... (+3)
  • Guy Sips
  • Mathijs Geerts Danau
  • Wim Hoste
 PRESS RELEASE

dsm-firmenich issues €1.5 billion long-term bonds

dsm-firmenich issues €1.5 billion long-term bonds Press Release dsm-firmenich issues €1.5 billion long-term bonds Kaiseraugst (Switzerland), Maastricht (Netherlands), February 17 2026 dsm-firmenich today announces the successful launch of a €1.5 billion dual-tranche bond issuance, consisting of: €750 million 3.00% fixed-rate notes due 2031€750 million 3.75% fixed-rate notes due 2038   The bonds will be issued by DSM B.V. and guaranteed by DSM-Firmenich AG pursuant to the previously established . The proceeds of the new bonds will be used for refinancing of existing bond maturities. ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch